• Buprenorphine/naloxone Aurovitas 2 mg/0.5 mg sublingual tablets EFG

  Form: tablets, sublingual

  Active substance	Dosage
  BUPRENORPHINE HYDROCHLORIDE	2,16 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	0,61 mg

  ATC: N07B N07BC N07BC51

  Manufacturer: Aurovitas Spain, S.A.U.

• Buprenorphine/naloxone Aurovitas 8 mg/2 mg sublingual tablets EFG

  Form: tablets, sublingual

  Active substance	Dosage
  BUPRENORPHINE HYDROCHLORIDE	8,64 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	2,44 mg

  ATC: N07B N07BC N07BC51

  Manufacturer: Aurovitas Spain, S.A.U.

• Duoxona 10 mg/5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	10 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	5,45 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Neuraxpharm Spain S.L.

• Duoxona 20 mg/10 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	20 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	10,9 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Neuraxpharm Spain S.L.

• Duoxona 30 mg/15 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	30 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	16,35 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Neuraxpharm Spain S.L.

• Duoxona 40 mg/20 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	40 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	21,8 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Neuraxpharm Spain S.L.

• Duoxona 5 mg/2.5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	5 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	2,74 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Neuraxpharm Spain S.L.

• Nyxoid 1.8 mg solution for nasal spray in single-dose container

  Form: solution, nasal spray, single-dose container

  Active substance	Dosage
  NALOXONE HYDROCHLORIDE DIHYDRATE	2,75 mg

  ATC: V03A V03AB V03AB15

  Manufacturer: Mundipharma Corporation (Ireland) Limited

• Oxycodone/naloxone Stada 10 mg/5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	10 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	5,45 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Laboratorio Stada S.L.

• Oxycodone/naloxone Stada 20 mg/10 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	20 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	10,90 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Laboratorio Stada S.L.

• Oxycodone/naloxone Stada 30 mg/15 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	30 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	16,35 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Laboratorio Stada S.L.

• Oxycodone/naloxone Stada 40 mg/20 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	40 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	21,80 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Laboratorio Stada S.L.

• Oxycodone/naloxone Stada 5 mg/2.5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	5 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	2,73 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Laboratorio Stada S.L.

• Oxycodone/naloxone Viatris 10 mg/5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	10 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	5 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Viatris Limited

• Oxycodone/naloxone Viatris 20 mg/10 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	20 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	5 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Viatris Limited

• Oxycodone/naloxone Viatris 40 mg/20 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	40 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	5,50 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Viatris Limited

• Oxycodone/naloxone Viatris 5 mg/2.5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	5 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	2,50 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Viatris Limited

• Taioma Plus 10 mg/5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	10 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	5,45 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Aristo Pharma Iberia S.L.

• Taioma Plus 20 mg/10 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	20 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	10,90 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Aristo Pharma Iberia S.L.

• Taioma Plus 30 mg/15 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	30 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	16,35 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Aristo Pharma Iberia S.L.

• Taioma Plus 40 mg/20 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	40 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	21,80 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Aristo Pharma Iberia S.L.

• Taioma Plus 5 mg/2.5 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  OXYCODONE HYDROCHLORIDE	5 mg
  NALOXONE HYDROCHLORIDE DIHYDRATE	2,74 mg

  ATC: N02A N02AA N02AA55

  Manufacturer: Aristo Pharma Iberia S.L.